M. Sanchez De La Torre (Lleida, Spain), . Deleanu (Bucharest, Romania)
Inhibition of miR-34a protects human umbilical vein endothelial cells against intermittent hypoxia-induced endothelial injury by targeting ATG7
Q. Chen (Quanzhou, China), G. Lin (Quanzhou, China), H. Lin (Quanzhou, China), Q. Lin (Fuzhou, China)
|  |
Inhibition of LncRNA MALAT1 Protects H9c2 Cells against Intermittent Hypoxia-Induced Injury by Targeting MiRNA-193a-3p
Q. Chen (Quanzhou, China), G. Lin (Quanzhou, China), H. Lin (Quanzhou, China), Q. Lin (Fuzhou, China)
| |
The role of complement factor H and clusterin in obstructive sleep apnoea
A. Bikov (Manchester, United Kingdom), M. Meszaros (Budapest, Hungary), P. Horvath (Budapest, Hungary), Z. Lazar (Budapest, Hungary), D. Tarnoki (Budapest, Hungary), A. Tarnoki (Budapest, Hungary), A. Kis (Budapest, Hungary), L. Kunos (Budapest, Hungary)
|  |
The role of hyaluronan metabolism in obstructive sleep apnoea
M. Meszaros (Budapest, Hungary), Z. Lazar (Budapest, Hungary), A. Tarnoki (Budapest, Hungary), D. Tarnoki (Budapest, Hungary), A. Kis (Budapest, Hungary), L. Kunos (Budapest, Hungary), A. Bikov (Manchester, United Kingdom)
| |
Peculiarities of GABA levels in plasma and urine of asthma patients with obstructive sleep apnea
E. Sheludko (Blagoveshchensk (Amur Oblast), Russian Federation), D. Naumov (Blagoveshchensk (Amur Oblast), Russian Federation), D. Gassan (Blagoveshchensk (Amur Oblast), Russian Federation), O. Kotova (Blagoveshchensk (Amur Oblast), Russian Federation), J. Perelman (Blagoveshchensk (Amur Oblast), Russian Federation)
| |
IFN? involvement in adipogenesis of OSA patients
Y. Wang (Beijing , China), X. Zhang (Beijing , China)
| |
Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study
D. Raptis (Larissa, Greece), F. Malli (Larissa, Greece), G. Rapti (Larissa, Greece), D. Siachpazidou (Larissa, Greece), C. Marogianni (Larissa, Greece), Z. Daniil (Larissa, Greece), I. Dimeas (Larissa, Greece), G. Giamouzis (Larissa, Greece), C. Pastaka (Larissa, Greece), G. Xiromerisiou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece)
| |
Socioeconomic factors and adherence to Continuous Positive Airway Pressure - a population-based cohort study
A. Palm (Uppsala, Sweden), L. Grote (Gothenburg, Sweden), M. Ljunggren (Uppsala, Sweden), J. Sundh (Örebro, Sweden), J. Theorell_haglöw (Uppsala, Sweden), M. Ekström (Uppsala, Sweden)
| |
CPAP and me: what's wrong?
P. Righini (Torino (TO), Italy), V. Gallo (Torino (TO), Italy), G. Ferrari (Torino (TO), Italy), D. Favero (Torino (TO), Italy), A. Oliva (Torino (TO), Italy), S. Bassini (Torino (TO), Italy), R. Prota (Torino (TO), Italy)
| |
CPAP usage patterns in OSA patients with suboptimal adherence
F. Grewe (Zurich, Switzerland), M. Bradicich (Zurich, Switzerland), T. Gaisl (Zurich, Switzerland), M. Roeder (Zurich, Switzerland), S. Thiel (Zurich, Switzerland), N. Sievi (Zurich, Switzerland), M. Kohler (Zurich, Switzerland)
| |
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
A. Lopes (Lisboa, Portugal), N. Cortesão (Porto, Portugal), I. Pinto (Lisboa, Portugal), M. Dias (Porto, Portugal), I. Teixeira (Porto, Portugal)
| |
Abandon of the arousal index for continuous positive airway pressure prescription and refund decreases short-term adherence to the treatment
G. Liistro (Bruxelles, Belgium), A. Dermine (Bruxelles, Belgium)
| |
Adherence to Continuous Positive Airways Pressure (CPAP) in mild obstructive sleep apnoea (OSA)
S. Coelho (Birmingham, United Kingdom), R. Glover (Birmingham, United Kingdom), M. Thomas (Birmingham, United Kingdom), Y. Khan (Birmingham, United Kingdom), D. Mukherjee (Birmingham, United Kingdom), A. Al Helou (Birmingham, United Kingdom), M. Daniels (Birmingham, United Kingdom), S. Wharton (Birmingham, United Kingdom), R. Mukherjee (Birmingham, United Kingdom)
| |
Tele-monitoring system implementation in continuous positive airway pressure therapy in Asian obstructive sleep apnea
W. Chumpangern (Bangkok, Thailand), N. Chirakalwasan (Bangkok, Thailand)
| |
Impact in adherence to CPAP treatment of a specific consultation for patients with severo obstructive sleep apnoea
J. Lancha Dominguez (Huelva, Spain), M. Morón Ortiz (Huelva, Spain), R. Del Pozo Rivas (Huelva, Spain), B. Urizar Catalán (Huelva, Spain), J. Hilares Vera (Huelva, Spain)
| |
FOLLOW-UP OF OBSTRUCTIVE SLEEP APNEA TREATMENT: DIFFICULTIES FACED BY PRIMARY CARE UNITS
A. Carvalho da Silva Almendra (Braga, Portugal), C. Pereira (Braga, Portugal), J. Carvalho (Braga, Portugal), P. Pinto (Braga, Portugal), C. Bárbara (Braga, Portugal)
| |
COMPLIANCE OF A NEW VIBRATIL DEVICE IN PATIENTS WITH POSTURAL SLEEP APNEA. Data not show.
L. Hidalgo Armas (Vitoria, Spain), J. Cordero-Guevara (Lleida, Spain), J. Durán-Cantolla (Lleida, Spain)
| |
Outcome of Mandibular Advancement Device (MAD) referrals following a clinician led dental assessment in patients with Obstructive Sleep Apnoea Syndrome (OSAS)
A. Witton (Wakefield (West Yorkshire), United Kingdom), L. Earnshaw (Wakefield (West Yorkshire), United Kingdom), A. Upson (Wakefield (West Yorkshire), United Kingdom), C. Ledgway (Wakefield (West Yorkshire), United Kingdom), M. Khan (Wakefield (West Yorkshire), United Kingdom), A. Johnson (Wakefield (West Yorkshire), United Kingdom), A. Dwarakanath (Wakefield (West Yorkshire), United Kingdom)
| |